Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Pott

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Seminars in Hematology|July 26, 2011
Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevanceChristiane Pott
Haematologica|April 9, 2026
Relapse as a return, not a reinvention - genomic stability and pre-existing resistance in mantle cell lymphomaChristiane Pott
Hematology. American Society of Hematology. Education Program|December 4, 2016
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatmentEva Hoster, Christiane Pott
Hematology/Oncology Clinics of North America|August 31, 2020
Minimal Residual Disease in Mantle Cell Lymphoma: Methods and Clinical SignificanceMarco Ladetto, Rita Tavarozzi, Christiane Pott
Journal of Business Economics|November 28, 2023
COVID-19 pandemic and capital markets: the role of government responsesChristian Beer, Janine Maniora, Christiane Pott
Deutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Malignant lymphomas - quo vadis? - What developments await us in diagnostics and therapy?]Stefan Alig, Christiane Pott, Björn Chapuy
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2020
Next-Generation Sequencing Technology to Identify Minimal Residual Disease in Lymphoid MalignanciesMichaela Kotrova, Nikos Darzentas, Christiane Pott, et al.
Acta Haematologica|June 5, 2004
Significance of minimal residual disease in lymphoid malignanciesMonika Brüggemann, Christiane Pott, Matthias Ritgen, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2022
cfDNA-Based NGS IG Analysis in LymphomaChristiane Pott, Michaela Kotrova, Nikos Darzentas, et al.
Genes|July 2, 2021
Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic CellsMichaela Kotrova, Nikos Darzentas, Christiane Pott, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Seminars in Hematology|July 26, 2011
Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevanceChristiane Pott
Haematologica|April 9, 2026
Relapse as a return, not a reinvention - genomic stability and pre-existing resistance in mantle cell lymphomaChristiane Pott
Hematology. American Society of Hematology. Education Program|December 4, 2016
Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatmentEva Hoster, Christiane Pott
Hematology/Oncology Clinics of North America|August 31, 2020
Minimal Residual Disease in Mantle Cell Lymphoma: Methods and Clinical SignificanceMarco Ladetto, Rita Tavarozzi, Christiane Pott
Journal of Business Economics|November 28, 2023
COVID-19 pandemic and capital markets: the role of government responsesChristian Beer, Janine Maniora, Christiane Pott
Deutsche Medizinische Wochenschrift (1946)|May 15, 2024
[Malignant lymphomas - quo vadis? - What developments await us in diagnostics and therapy?]Stefan Alig, Christiane Pott, Björn Chapuy
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2020
Next-Generation Sequencing Technology to Identify Minimal Residual Disease in Lymphoid MalignanciesMichaela Kotrova, Nikos Darzentas, Christiane Pott, et al.
Acta Haematologica|June 5, 2004
Significance of minimal residual disease in lymphoid malignanciesMonika Brüggemann, Christiane Pott, Matthias Ritgen, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 27, 2022
cfDNA-Based NGS IG Analysis in LymphomaChristiane Pott, Michaela Kotrova, Nikos Darzentas, et al.
Genes|July 2, 2021
Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic CellsMichaela Kotrova, Nikos Darzentas, Christiane Pott, et al.
Pageof 12